NASDAQ · EXOZ
Healthcare · Biotechnology
$4.13
Up+$0.02 (+0.49%)
Updated Oct 31, 2026, 10:16 PM
SID Score
2.7/10
Composite research score
Smart Money
—
Institutional and insider signal
Price performance · EXOZ
1M range · 21 trading sessions · Daily adjusted prices
Prices through Oct 30, 2026
EXOZ closed at $4.13 after 21 trading sessions, down 28.42% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 30, 2026 | $4.18 | $4.19 | $4.01 | $4.13 | 6.11K |
| Oct 29, 2026 | $4.30 | $4.31 | $4.00 | $4.11 | 9.23K |
| Oct 28, 2026 | $3.74 | $4.57 | $3.682 | $4.225 | 16.75K |
| Oct 27, 2026 | $3.79 | $4.0457 | $3.24 | $3.80 | 16.65K |
| Oct 26, 2026 | $4.00 | $4.40 | $3.75 | $3.75 | 16.57K |
| Oct 23, 2026 | $3.88 | $4.44 | $3.85 | $4.00 | 14.31K |
| Oct 22, 2026 | $3.80 | $4.64 | $3.80 | $3.90 | 26.49K |
| Oct 21, 2026 | $4.15 | $4.70 | $3.92 | $3.92 | 19.97K |
| Oct 20, 2026 | $4.1998 | $4.435 | $4.03 | $4.12 | 4.31K |
| Oct 19, 2026 | $4.2976 | $4.52 | $3.85 | $4.00 | 8.84K |
| Oct 16, 2026 | $4.085 | $4.96 | $4.02 | $4.09 | 32.09K |
| Oct 15, 2026 | $4.60 | $4.881 | $3.705 | $4.00 | 24.36K |
| Oct 14, 2026 | $4.51 | $4.80 | $4.51 | $4.60 | 7.59K |
| Oct 13, 2026 | $5.0476 | $5.075 | $4.55 | $4.59 | 20.58K |
| Oct 12, 2026 | $5.30 | $5.30 | $5.05 | $5.05 | 9.39K |
| Oct 9, 2026 | $5.335 | $5.41 | $5.25 | $5.25 | 1.03K |
| Oct 8, 2026 | $5.69 | $6.34 | $5.27 | $5.27 | 22.33K |
| Oct 7, 2026 | $5.55 | $5.71 | $5.52 | $5.54 | 7.55K |
| Oct 6, 2026 | $5.64 | $5.72 | $5.52 | $5.52 | 1.83K |
| Oct 5, 2026 | $5.85 | $5.85 | $5.51 | $5.52 | 4.45K |
| Oct 2, 2026 | $5.87 | $6.00 | $5.762 | $5.77 | 2.12K |
The latest Smart Investors Daily articles mentioning EXOZ.
Company
Market Activity
Research & News
EXOZ research
Company profile and research snapshot.
EXoZymes Inc is focused on using a biomanufacturing platform to create valuable biochemicals, including Active Pharmaceutical Ingredients or APIs, biofuels, food flavors, and cosmetics, offering a sustainable alternative to traditional chemical production methods.
Visit company websiteConsensus and target data currently published for this company.
No generated briefing is available yet.
Yahoo · Oct 21, 2026
* October 22 investor event will explore ' commercialization, manufacturing economics, path to market launch, growth strategy, and milestones ahead.LOS ANGELES, CA / ACCESS Newswire / October 21, 2026 / Today, Inc.
Yahoo · Sep 8, 2026
* Program expected to commence in Q4 2026 and establish a roadmap for larger-scale production in 2027LOS ANGELES, CA / ACCESS Newswire / September 8, 2026 / Today, Inc. (NASDAQ:EXOZ) ("") - a pioneer of AI-enhanced enzymes that transform abundant feedstock into valuable nutraceuticals and novel medicines - announced that it has entered into an agreement with Curia Global, Inc.
Benzinga · Aug 20, 2026
Gainers Werewolf Therapeutics (NASDAQ:HOWL) stock moved upwards by 77.1% to $0.76 during Thursday's after-market session. The company's market cap stands at $19.8 million. Profusa (NASDAQ:PFSA) stock rose
Yahoo · Aug 11, 2026
Today, eXoZymes Inc. (NASDAQ:EXOZ) ("eXoZymes") - a pioneer of AI-enhanced enzymes that transform abundant feedstock into valuable nutraceuticals and novel medicines - announced the plan to host a webinar on Thursday, August 20, 2026, at 5:00 PM Eastern ...
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning EXOZ.
